Activation of phospholipase D in SH-SY5Y neuroblastoma cells: dependence on Ca2+ and protein kinase C.
Purkiss
J R
JR
Department of Cell Physiology and Pharmacology, University of Leicester, U.K.
D001920:Bradykinin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D007700:Kinetics; D016210:Methacholine Chloride / Q000494:pharmacology; D018721:Muscarinic Agonists / Q000494:pharmacology; D009447:Neuroblastoma / Q000378:metabolism; D010739:Phospholipase D / Q000378:metabolism*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013729:Terpenes / Q000494:pharmacology; D019284:Thapsigargin; D014407:Tumor Cells, Cultured
D004791:Enzyme Inhibitors; D007211:Indoles; D018721:Muscarinic Agonists; D013729:Terpenes; D016210:Methacholine Chloride; D019284:Thapsigargin; D011493:Protein Kinase C; D010739:Phospholipase D; D000252:Calcium-Transporting ATPases; D001920:Bradykinin; D002118:Calcium; C064758:Ro 31-8220